Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes

Drug and Alcohol Dependence

Volumn 122, Issue 3, 2012, Pages 213-219

  Jansson, L M ^a   Di Pietro, J A ^b   Elko, A ^a   Williams, E L ^b   Milio, L ^a   Velez, M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Fetal neurobehavior; Methadone; Neonatal abstinence syndrome; Poly drug exposure

Indexed keywords

ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; BEHAVIOR DISORDER; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FETUS HEART RATE; FETUS MONITORING; GESTATIONAL AGE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NEUROTOXICITY; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; FEMALE; FETAL MONITORING; HUMANS; INFANT, NEWBORN; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; POLYPHARMACY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; STREET DRUGS;

EID: 84859650788     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.10.003     Document Type: Article

References (39)

1. Anyaegbunam A., Tran T., Jadali D., Randolph G., Mikhail M. Assessment of fetal well-being in methadone-maintained pregnancies: abnormal stress tests. Gynecol. Obstet. Invest. 1997, 43:25-28.
2. Archie C., Lee M., Sokol R., Norman G. The effects of methadone treatment on the reactivity of the non-stress test. Obstet. Gynecol. 1989, 74:254-255.
3. Cejtin H., Mills A., Swift E. Effect of methadone on the biophysical profile. J. Reprod. Med. 1996, 41:819-822.
4. Chasnoff I.J., Hatcher R., Burns W.J. Polydrug- and methadone-addicted newborns: a continuum of impairment?. Pediatrics 1982, 70:210-213.
5. Cotes C.D., Smith I., Fernhoff P.M., Fatek A. Neonatal neuroalcoholism: clinical experimental research. Behavioral characteristics as correlates of maternal alcohol use during gestation. Alcohol. Clin. Exp. Res. 1985, 9:454.
6. D'Apolito K. Most prominent symptoms of withdrawal in polydrug-exposed infants. Tenn. Nurse 2001, 20:22-24.
7. DiPietro J., Costigan K., Shupe A., Pressman E. Fetal neurobehavioral development: associations with socioeconomic class and fetal sex. Dev. Psychobiol. 1998, 33:79-91.
8. DiPietro J.A., Irizarry R.A., Hawkins M., Costigan K.A., Pressman E.K. Cross-correlation of fetal cardiac and somatic activity as an indicator of antenatal neural development. Am. J. Obstet. Gynecol. 2001, 185:1421-1428.
9. DiPietro J.A., Kivlighan K.T., Costigan K.A., Rubin S.E., Shiffler D.E., Henderson J.L., Pillion J.P. Prenatal antecedents of newborn neurologic maturation. Child Dev. 2010, 81:115-130.
10. Finnegan L. Treatment issues for opioid-dependent women during the perinatal period. J. Psychoactive Drugs 1991, 23:191-201.
11. Gustavvson N.S. Drug exposed infants and their mothers: facts, myths and needs. Soc. Work Health Care 1992, 16:87-100.
12. Handelsman L., Cochrane K.J., Aronson M.J., Ness R.A., Rubinstein K.J., Kanof P.D. Two new rating scales for opiate withdrawal. Am. J. Drug Alcohol Abuse 1987, 13:293-308.
13. Jansson L.M., Svikis D., Lee J., Paluzzi P., Rutigliano P., Hackerman F. Pregnancy and addiction: a comprehensive care model. J. Subst. Abuse Treat. 1996, 13:321-329.
14. Jansson L.M., Elko A., DiPietro J. Fetal response to maternal methadone administration. Am. J. Obstet. Gynecol. 2005, 193:611-617.
15. Jansson L.M., DiPietro J.A., Elko A., Velez M. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates. J. Matern. Fetal Neonatal Med. 2007, 20:677-685.
16. Jansson L.M., DiPietro J.A., Velez M., Elko A., Knauer H., Kivlighan K.T. Maternal methadone dosing schedule and fetal neurobehavior. J. Matern. Fetal Neonatal Med. 2009, 22:29-35.
17. Jansson L.M., Velez M., Harrow C. The opioid exposed newborn: assessment and pharmacologic management. J. Opioid Manage. 2009, 5:47-58.
18. Jansson L.M., DiPietro J.A., Elko A., Velez M. Infant autonomic functioning and neonatal abstinence syndrome. Drug Alcohol Depend. 2010, 109:198-204.
19. Jones H.E., Velez M.L., McCaul M.E., Svikis D.S. Special treatment issues for women. Methadone Treatment for Opiate Dependence 1999, 251-280. Johns Hopkins University Press, Baltimore. E.C. Strain, M. Stitzer (Eds.).
20. Kaltenbach K., Finnegan L.P. Prenatal narcotic exposure: perinatal and developmental effects. Neurotoxicology 1989, 10:597-604.
21. Law K.L., Stroud L.R., LaGasse L.L., Niaura R., Liu J., Lester B.M. Smoking during pregnancy and newborn neurobehavior. Pediatrics 2003, 111:1318-1323.
22. Lester B.M., Tronick E.Z., LaGasse L., Seifer R., Bauer C.R., Shankaran S., Bada H., Wright L.L., Smeriglio V.L., Liu J., Finnegan L.P., Maza P.L. The Maternal Lifestyle Study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002, 110:1182-1192.
23. Lester B.M., Andreozzi L., Appiah L. Substance use during pregnancy: time for policy to catch up with research. Harm Reduct. J. 2004, 1:5.
24. Lester B.M., Bagner D.M., Liu J., LaGasse L.L., Seifer R., Bauer C.R., Shankaran S., Bada H., Higgins R.D., Das A. Infant neurobehavioral dysregulation related to behavior problems in children with prenatal substance exposure. Pediatrics 2009, 124:1355-1362.
25. Lester B.M., Lagasse L.L. Children of addicted women. J. Addict. Dis. 2010, 29:259-276.
26. Levine A., Rebarber A. Methadone maintenance treatment and the nonstress test. J. Perinatol. 1995, 15:229-231.
27. Lifschitz M.H., Wilson G.S., Smith E.O., Desmond M.M. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985, 75:269-274.
28. Liu J., Bann C., Lester B., Tronick E., Das A., Lagasse L., Bauer C., Shankaran S., Bada H. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics 2010, 125:e90-e98.
29. Moeller K.E., Lee K.C., Kissack J.C. Urine drug screening: a practical guide for clinicians. May Clin. Proc. 2008, 83:66-76.
30. Rampono J., Simmer K., Ilett K.F., Hackett L.P., Doherty D.A., Elliot R., Kok C.H., Coenen A., Forman T. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009, 42:95-100.
31. Reddy U.M., Bettegowda V.R., Dias T., Yamada-Kushnir T., Ko C.W., WIllinger M. Term pregnancy: a period of heterogrneous risk for infant mortality. Obstet. Gynecol. 2011, 117:1279-1287.
32. Salisbury A.L., Ponder K.L., Padbury J.F., Lester B.M. Fetal effects of psychoactive drugs. Clin. Perinatol. 2009, 36:595-619.
33. Stroud L.R., Paster R.L., Papandonatos G.D., Niaura R., Salisbury A.L., Battle C., Lagasse L.L., Lester B.J. Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. Pediatrics 2009, 154:10-16.
34. Srivasta A., Kahan M. Methadone induction doses: are our current practices safe?. J. Addict. Dis. 2006, 25:6-13.
35. Tuten M., Fitzsimons H., Chisolm M., Jones H.E., Heil S.H., O'Grady K.E. The impact of mood disorders on the delivery and neonatal outcomes of methadone-maintained pregnant patients. Am. J. Drug Alcohol Use 2009, 35:358-363.
36. US Department of Health and Human Services, 2005. Treatment Improvement Protocol (TIP) Series 43: Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse, Rockville, MD.
37. Velez M.L., Jansson L.M., Williams E., Schroeder J. Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr. Res. 2009, 66:704-709.
38. Vrekoussis T., Kalantaridou S.N., Mastorakos G., Zoumakis E., Makrigiannakis A., Syrrou M., Lavasidis L.G., Relakis K., Chrousos G.P. The role of stress in female reproduction and pregnancy: an update. Ann. NY Acad. Sci. 2010, 1205:69-75.
39. Wouldes T., Roberts A., Pryor J., Bagnall C., Gunn T. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol. Teratol. 2004, 26:23-34.